For UK HealthTech companies
Your marketing spend is reaching NHS inboxes, not NHS decision-makers
Clinical leads, digital leads, finance directors, and ICS commissioners each hold a slice of procurement authority, and each responds to different messages. Generic campaigns miss all of them, while qualified leads come at a steep cost apiece.
Two minutes. Solva follows up with specific stakeholder mapping options.
- Low attendance or engagement at generic webinars and events.
- High bounce rates on website content not tailored to specific NHS roles.
- Sales teams struggling to convert leads due to poor qualification.
- Marketing campaigns failing to generate meaningful conversations with key NHS stakeholders.
- Inefficient allocation of marketing resources and budget.
- Increased workload for sales teams chasing unqualified leads.
- Wasted marketing spend on ineffective channels, potentially tens of thousands of pounds annually.
- Reduced sales revenue and slower growth due to poor lead quality.
- Perception as a generic vendor rather than a specialist solution provider.
- Difficulty in building trust and credibility with NHS decision-makers.
Organisations that align their marketing efforts with customer personas are three times more likely to reach business goals (Cintell Study, 2016)
Frequently asked questions
Why does this problem persist?
NHS decision-making is distributed across clinical leads, digital leads, finance directors, and ICS commissioners - and each has different priorities. Generic marketing reaches none of them effectively.
What is the cost of leaving it unaddressed?
The average cost per qualified lead for Healthcare SaaS in the UK is £160 to £400 (Leadriver, 2026). Conference and event marketing costs can range significantly, with B2B teams spending upwards of £40,000 on a conference booth (LinkedIn, 2026).
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.